Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forest Launches Combunox And Campral Without Adding Sales Reps

Executive Summary

Forest's Combunox and Campral launches do not necessitate an expansion of the sales force at this time, President Kenneth Goodman said April 19 during an investor call

You may also be interested in...



GSK Launching Vesicare, Boniva Without Adding Reps; “Efficiency” Is Key

GlaxoSmithKline is launching Vesicare and Boniva without increasing the size of its sales force

GSK Launching Vesicare, Boniva Without Adding Reps; “Efficiency” Is Key

GlaxoSmithKline is launching Vesicare and Boniva without increasing the size of its sales force

Campral Clears FDA For Alcohol Dependence: Renal Study Part Of Phase IV

Merck KGaA subsidiary Lipha will determine appropriate Campral dosing in patients with severe renal impairment as a postmarketing commitment following FDA approval of the alcoholism therapy

Related Content

Topics

UsernamePublicRestriction

Register

PS045707

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel